Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism GIP modulators(Gastric inhibitory polypeptide modulators), GLP-1R modulators(Glucagon-like peptide 1 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Ousia Pharma ApSStartup |
Active Organization Ousia Pharma ApSStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | DK | Ousia Pharma ApSStartup | 29 May 2024 |